GLP-1 receptor agonists are a group of medications that mimic the natural GLP-1 hormone that is released in our body after consuming a meal
These can include minor discomfort, redness at the injection site, or mild digestive symptoms
This combination follows the same synergy principle that makes the injectable wolverine stack popular, applied to intranasal administration
Nuevo estudio: revelan los mltiples efectos secundarios de Ozempic, algunos impensados Un anlisis observacional con ms de dos millones de personas seala que los agonistas del GLP-1 reducen el riesgo de sufrir demencia, Alzheimer y adicciones
In addition, dyslipidemia is a frequent complication after KT and is a risk factor for the development of cardiovascular disease and graft loss.23 Furthermore, most immunosuppressive drugs used in transplantation have a detrimental effect on the lipid profile.24 These alterations have not been adequately analyzed in the previously published series of KT recipients treated with GLP-1 RAs.611 In our series, we observed a significant reduction in total cholesterol and LDLc, and it is interesting to note that there were no differences in the number of subjects who received statins or in the dose of those drugs
Now that weve covered GLP-1s and cleared up the confusion surrounding GLP-2s, lets talk about the newest term patients are hearing: GLP-3